Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells - PubMed (original) (raw)

Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells

Michael F Santillo et al. Toxicol In Vitro. 2014 Apr.

Abstract

Interactions among monoamine oxidase (MAO) inhibitors in drugs, botanicals, and dietary supplements may lead to unpredictable neurochemical dysfunction due to excessive inhibition or therapeutic invalidation. Often recombinant MAO or brain tissue homogenates have been used to evaluate MAO inhibitors such as the β-carboline alkaloids (harmane, harmine, harmaline, and harmalol). However, there is a lack of cellular systems for evaluation of MAO activity, which represents a more advanced in vitro model compared to recombinant enzymes or tissue lysates. Using kynuramine assays, intracellular MAO inhibition by β-carbolines was measured in PC12 (rat pheochromocytoma), MH1C1 (rat liver), and HuH-7 (human liver) cell lines, which were compared with human recombinant MAO and cell lysates. β-Carbolines (1 μM, 90 min incubations) inhibited MAO by 40-99% in live PC12 cells where MAO A was the active isoform, and <12% in HuH-7 and MH1C1 cells where MAO B was primarily active. The combination index (CI), which serves as a quantitative indicator of pharmacological interactions, was determined for harmaline/harmine (CI, 1.01-1.25) and methylene blue/harmine (CI, 0.74-1.07) in PC12 cells. Overall, this study illustrates applications of cell-based in vitro assay platforms to gain a comprehensive understanding of intracellular MAO inhibitors and their interactions.

Keywords: Botanical; Cell assay; Combination index; Harmaline; Harmine; Methylene blue.

Published by Elsevier Ltd.

PubMed Disclaimer

Cited by

Effects of small molecules on neurogenesis: Neuronal proliferation and differentiation.
Jastrzębski MK, Wójcik P, Stępnicki P, Kaczor AA. Jastrzębski MK, et al. Acta Pharm Sin B. 2024 Jan;14(1):20-37. doi: 10.1016/j.apsb.2023.10.007. Epub 2023 Oct 20. Acta Pharm Sin B. 2024. PMID: 38239239 Free PMC article. Review.
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.
Basagni F, Di Paolo ML, Cozza G, Dalla Via L, Fagiani F, Lanni C, Rosini M, Minarini A. Basagni F, et al. Molecules. 2023 Nov 4;28(21):7424. doi: 10.3390/molecules28217424. Molecules. 2023. PMID: 37959843 Free PMC article.
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs.
Nordio G, Piazzola F, Cozza G, Rossetto M, Cervelli M, Minarini A, Basagni F, Tassinari E, Dalla Via L, Milelli A, Di Paolo ML. Nordio G, et al. Molecules. 2023 Aug 29;28(17):6329. doi: 10.3390/molecules28176329. Molecules. 2023. PMID: 37687158 Free PMC article.
Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.
Tarpley M, Oladapo HO, Strepay D, Caligan TB, Chdid L, Shehata H, Roques JR, Thomas R, Laudeman CP, Onyenwoke RU, Darr DB, Williams KP. Tarpley M, et al. Eur J Pharm Sci. 2021 Jul 1;162:105821. doi: 10.1016/j.ejps.2021.105821. Epub 2021 Mar 27. Eur J Pharm Sci. 2021. PMID: 33781856 Free PMC article.
Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential.
Santos BWL, Oliveira RC, Sonsin-Oliveira J, Fagg CW, Barbosa JBF, Caldas ED. Santos BWL, et al. Plants (Basel). 2020 Jul 9;9(7):870. doi: 10.3390/plants9070870. Plants (Basel). 2020. PMID: 32660098 Free PMC article.

Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells - PubMed (original) (raw)